The Globe and Mail reports in its Friday edition that Stifel analyst Ian Gillies has reaffirmed his "buy" recommendation for Atkinsrealis Group. The Globe's David Leeder writes in the Eye On Equities column that Mr. Gillies boosted his share target by a loonie to $109. Analysts on average target the shares at $102.33. Mr. Gillies calls Atkinsrealis "catalyst rich" and continues to see its shares as "undervalued" following the close of the sale of its interest in Highway 407 for net proceeds of $2.5-billion and the repurchase of seven million shares for $636-million from Caisse de depot et placement du Quebec. Mr. Gillies says in a note: "We have a positive view on the use of proceeds. The company's current M&A playbook is focused on small to mid-sized deals like the $300-million (U.S.) David Evans acquisition, which was executed on February 19, 2025. As such, Atkinsrealis would have required a number of years to work through its underlevered balance sheet. This share repurchase from La Caisse is being executed at 2026E multiples of 11.8 times EV/EBITDA and 21.8 times P/E. In our view, these valuation metrics are comparable to what the company would need to pay for well functioning mid-sized engineering businesses."